SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-002982
Filing Date
2018-01-04
Accepted
2018-01-04 16:31:32
Documents
4
Period of Report
2017-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d488954d8k.htm 8-K 21982
2 EX-10.1 d488954dex101.htm EX-10.1 195402
3 EX-99.1 d488954dex991.htm EX-99.1 12839
4 GRAPHIC g488954logo.jpg GRAPHIC 5140
  Complete submission text file 0001193125-18-002982.txt   238666
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 18510524
SIC: 2834 Pharmaceutical Preparations